Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

BARRY J KUTTNER

Allopathic & Osteopathic Physicians Dermatology

NPI
1487614293
CMS profile
111852
Location
DELRAY BEACH, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2021 · Entire year

$264.26

16 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2021 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $264.26 16

By paying entity

PY2021 · entire year · sorted by reported total

Paying entityAmountRecords
PFIZER INC. $73.56 7
Bausch Health US, LLC $45.00 1
UCB, Inc. $39.48 2
Regeneron Healthcare Solutions, Inc. $39.34 2
Amgen Inc. $31.12 2
Biofrontera Inc. $20.97 1
Janssen Biotech, Inc. $14.79 1

Page 1 of 1; records 1–16 of 16 matching records. This page contains 16 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

BARRY J KUTTNER

NPI 1487614293 · CMS profile ID 111852

Allopathic & Osteopathic Physicians / Dermatology

DELRAY BEACH, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–16 of 16 matching records. This page contains 16 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1487614293?year=2021&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
BARRY J KUTTNER, NPI 1487614293, CMS profile ID 111852. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–16 of 16 matching records. This page contains 16 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1487614293?year=2021&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
APA 7
IndustryPayments. (2026). BARRY J KUTTNER, NPI 1487614293, CMS profile ID 111852. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–16 of 16 matching records. This page contains 16 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1487614293?year=2021&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
Bluebook
BARRY J KUTTNER, NPI 1487614293, CMS profile ID 111852, IndustryPayments, General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–16 of 16 matching records. This page contains 16 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202. https://industrypayments.org/provider/npi-1487614293?year=2021&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2021 · Physicians and non-physician practitioners · CMS publication 2026-06-30

16 matching records · $264.26 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 16 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–16 of 16.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
PFIZER INC. $3.8011/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 833287117 CMS
PFIZER INC. $11.6911/15/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 833254299 CMS
Regeneron Healthcare Solutions, Inc. $17.8011/03/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 809596629 CMS
PFIZER INC. $2.7210/13/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 833287119 CMS
Amgen Inc. $14.1709/30/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 825173255 CMS
Regeneron Healthcare Solutions, Inc. $21.5409/02/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 809596627 CMS
PFIZER INC. $15.4607/27/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 832580483 CMS
Biofrontera Inc. $20.9707/22/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 803505415 CMS
UCB, Inc. $21.1707/07/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 807407721 CMS
Bausch Health US, LLC $45.0006/03/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 851555129 CMS
PFIZER INC. $13.2605/26/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 832613849 CMS
UCB, Inc. $18.3105/21/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 807365125 CMS
Amgen Inc. $16.9505/19/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 826301165 CMS
PFIZER INC. $13.4304/06/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 832751507 CMS
PFIZER INC. $13.2001/28/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 832631817 CMS
Janssen Biotech, Inc. $14.7901/26/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788303927 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $47.55 3
PY2020 $77.30 5
PY2021 $264.26 16
PY2022 $165.30 8
PY2023 $138.69 6
PY2024 $4.04 1
PY2025 $51.95 2

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2024 Principal investigator $700.00 1
PY2023 Principal investigator $16,868.27 29
PY2022 Principal investigator $44,738.46 42
PY2021 Recipient $11,453.00 4
PY2021 Principal investigator $67,841.53 50
PY2020 Principal investigator $261,290.81 68
PY2019 Recipient $27,860.00 6
PY2019 Principal investigator $204,941.02 55

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2019

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

61 records in PY2019

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 AbbVie, Inc. $9,550.00 12/12/2019 Non-covered Recipient Entity
Integrated Clinical Research, LLC
M16-045 No dispute reported 06/30/2026 647589657
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $650.00 12/06/2019 Non-covered Recipient Entity
INTEGRATED CLINICAL RESEARCH LLC
A PROSPECTIVE OBSERVATIONAL STUDY OF ADULT PATIENTS RECEIVING DUPIXENT FOR ATOPIC DERMATITIS No dispute reported 06/30/2026 639735075
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $300.00 12/06/2019 Non-covered Recipient Entity
INTEGRATED CLINICAL RESEARCH LLC
A PROSPECTIVE OBSERVATIONAL STUDY OF ADULT PATIENTS RECEIVING DUPIXENT FOR ATOPIC DERMATITIS No dispute reported 06/30/2026 639735077
Principal investigator 1 AbbVie, Inc. $3,447.50 11/27/2019 Non-covered Recipient Entity
Integrated Clinical Research, LLC
M16-766 No dispute reported 06/30/2026 647589677
Principal investigator 1 AbbVie, Inc. $4,287.50 11/13/2019 Non-covered Recipient Entity
Integrated Clinical Research, LLC
M16-045 No dispute reported 06/30/2026 647589659
Principal investigator 1 LEO Pharma AS $2,764.00 11/12/2019 Non-covered Recipient Entity
INTEGRATED CLINICAL RESEARCH LLC
TRALOKINUMAB MONOTHERAPY FOR MODERATE TO SEVERE ATOPIC DERMATITIS - ECZTRA 1 ECZEMA TRALOKINUMAB TRIAL NO. 1 ECZTRA 1 No dispute reported 06/30/2026 686860671
Principal investigator 1 LEO Pharma AS $1,427.00 10/31/2019 Non-covered Recipient Entity
INTEGRATED CLINICAL RESEARCH LLC
LONG-TERM EXTENSION TRIAL IN SUBJECTS WITH ATOPIC DERMATITIS WHO PARTICIPATED IN PREVIOUS TRALOKINUMAB TRIALS - ECZTEND No dispute reported 06/30/2026 686860269
Principal investigator 1 AbbVie, Inc. $4,377.50 10/30/2019 Non-covered Recipient Entity
Integrated Clinical Research, LLC
M16-766 No dispute reported 06/30/2026 647589673
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $300.00 10/18/2019 Non-covered Recipient Entity
INTEGRATED CLINICAL RESEARCH LLC
A PROSPECTIVE OBSERVATIONAL STUDY OF ADULT PATIENTS RECEIVING DUPIXENT FOR ATOPIC DERMATITIS No dispute reported 06/30/2026 639735071
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $300.00 10/18/2019 Non-covered Recipient Entity
INTEGRATED CLINICAL RESEARCH LLC
A PROSPECTIVE OBSERVATIONAL STUDY OF ADULT PATIENTS RECEIVING DUPIXENT FOR ATOPIC DERMATITIS No dispute reported 06/30/2026 639735073
Principal investigator 1 AbbVie, Inc. $500.00 10/15/2019 Non-covered Recipient Entity
Integrated Clinical Research, LLC
M16-045 No dispute reported 06/30/2026 647589653
Principal investigator 1 AbbVie, Inc. $1,519.27 10/15/2019 Non-covered Recipient Entity
Integrated Clinical Research, LLC
M16-045 No dispute reported 06/30/2026 647589655
Principal investigator 1 AbbVie, Inc. $15,113.00 10/11/2019 Non-covered Recipient Entity
Integrated Clinical Research, LLC
M16-045 No dispute reported 06/30/2026 647589651
Principal investigator 1 AbbVie, Inc. $6,210.00 10/02/2019 Non-covered Recipient Entity
Integrated Clinical Research, LLC
M16-766 No dispute reported 06/30/2026 647589675
Principal investigator 1 AbbVie, Inc. $5,672.50 09/09/2019 Non-covered Recipient Entity
Integrated Clinical Research, LLC
M16-045 No dispute reported 06/30/2026 647589649
Principal investigator 1 AbbVie, Inc. $2,752.50 08/30/2019 Non-covered Recipient Entity
Integrated Clinical Research, LLC
M16-045 No dispute reported 06/30/2026 647589647
Principal investigator 1 AbbVie, Inc. $7,945.00 08/29/2019 Non-covered Recipient Entity
Integrated Clinical Research, LLC
M16-766 No dispute reported 06/30/2026 647589669
Principal investigator 1 LEO Pharma AS $673.00 08/06/2019 Non-covered Recipient Entity
INTEGRATED CLINICAL RESEARCH LLC
LONG-TERM EXTENSION TRIAL IN SUBJECTS WITH ATOPIC DERMATITIS WHO PARTICIPATED IN PREVIOUS TRALOKINUMAB TRIALS - ECZTEND No dispute reported 06/30/2026 686857491
Principal investigator 1 AbbVie, Inc. $7,070.00 08/01/2019 Non-covered Recipient Entity
Integrated Clinical Research, LLC
M16-766 No dispute reported 06/30/2026 647589671
Principal investigator 1 AbbVie, Inc. $160.00 07/02/2019 Non-covered Recipient Entity
Integrated Clinical Research, LLC
M16-766 No dispute reported 06/30/2026 647589667
Principal investigator 1 AbbVie, Inc. $832.50 07/02/2019 Non-covered Recipient Entity
Integrated Clinical Research, LLC
M16-045 No dispute reported 06/30/2026 647589713
Principal investigator 1 AbbVie, Inc. $3,182.50 06/27/2019 Non-covered Recipient Entity
Integrated Clinical Research, LLC
M16-045 No dispute reported 06/30/2026 647589711
Principal investigator 1 AbbVie, Inc. $400.00 06/26/2019 Non-covered Recipient Entity
Integrated Clinical Research, LLC
M16-766 No dispute reported 06/30/2026 647589663
Principal investigator 1 AbbVie, Inc. $240.00 06/25/2019 Non-covered Recipient Entity
Integrated Clinical Research, LLC
M16-045 No dispute reported 06/30/2026 647589709
Principal investigator 1 AbbVie, Inc. $17,645.00 06/13/2019 Non-covered Recipient Entity
Integrated Clinical Research, LLC
M16-766 No dispute reported 06/30/2026 647589665
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $300.00 06/03/2019 Non-covered Recipient Entity
INTEGRATED CLINICAL RESEARCH LLC
A PROSPECTIVE OBSERVATIONAL STUDY OF ADULT PATIENTS RECEIVING DUPIXENT FOR ATOPIC DERMATITIS No dispute reported 06/30/2026 639735069
Principal investigator 1 AbbVie, Inc. $4,800.00 05/29/2019 Non-covered Recipient Entity
Integrated Clinical Research, LLC
M16-045 No dispute reported 06/30/2026 647589707
Principal investigator 1 LEO Pharma AS $1,427.00 05/29/2019 Non-covered Recipient Entity
INTEGRATED CLINICAL RESEARCH LLC
LONG-TERM EXTENSION TRIAL IN SUBJECTS WITH ATOPIC DERMATITIS WHO PARTICIPATED IN PREVIOUS TRALOKINUMAB TRIALS - ECZTEND No dispute reported 06/30/2026 686855501
Recipient Bausch Health US, LLC $2,000.00 05/24/2019 Covered Recipient Physician A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, VEHICLECONTROLLED, PARALLEL-GROUP, CLINICAL STUDY COMPARING THE EFFICACY AND SAFETY OF IDP-126 GEL IN THE TREATMENT OF ACNE VULGARIS No dispute reported 06/30/2026 684337727
Principal investigator 1 AbbVie, Inc. $3,556.25 05/03/2019 Non-covered Recipient Entity
Integrated Clinical Research, LLC
M16-766 No dispute reported 06/30/2026 647589661
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $300.00 05/02/2019 Non-covered Recipient Entity
INTEGRATED CLINICAL RESEARCH LLC
A PROSPECTIVE OBSERVATIONAL STUDY OF ADULT PATIENTS RECEIVING DUPIXENT FOR ATOPIC DERMATITIS No dispute reported 06/30/2026 639735063
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $300.00 05/02/2019 Non-covered Recipient Entity
INTEGRATED CLINICAL RESEARCH LLC
A PROSPECTIVE OBSERVATIONAL STUDY OF ADULT PATIENTS RECEIVING DUPIXENT FOR ATOPIC DERMATITIS No dispute reported 06/30/2026 639735065
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $300.00 05/02/2019 Non-covered Recipient Entity
INTEGRATED CLINICAL RESEARCH LLC
A PROSPECTIVE OBSERVATIONAL STUDY OF ADULT PATIENTS RECEIVING DUPIXENT FOR ATOPIC DERMATITIS No dispute reported 06/30/2026 639735067
Principal investigator 1 LEO Pharma AS $1,427.00 04/30/2019 Non-covered Recipient Entity
INTEGRATED CLINICAL RESEARCH LLC
LONG-TERM EXTENSION TRIAL IN SUBJECTS WITH ATOPIC DERMATITIS WHO PARTICIPATED IN PREVIOUS TRALOKINUMAB TRIALS - ECZTEND No dispute reported 06/30/2026 686854737
Principal investigator 1 AbbVie, Inc. $4,068.75 04/29/2019 Non-covered Recipient Entity
Integrated Clinical Research, LLC
M16-045 No dispute reported 06/30/2026 647589695
Recipient Bausch Health US, LLC $1,160.00 04/19/2019 Covered Recipient Physician A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, VEHICLECONTROLLED, PARALLEL-GROUP, CLINICAL STUDY COMPARING THE EFFICACY AND SAFETY OF IDP-126 GEL IN THE TREATMENT OF ACNE VULGARIS No dispute reported 06/30/2026 684337723
Principal investigator 1 AbbVie, Inc. $547.50 04/15/2019 Non-covered Recipient Entity
Integrated Clinical Research, LLC
M16-766 No dispute reported 06/30/2026 647589699
Principal investigator 1 AbbVie, Inc. $1,961.25 04/12/2019 Non-covered Recipient Entity
Integrated Clinical Research, LLC
M16-766 No dispute reported 06/30/2026 647589701
Principal investigator 1 AbbVie, Inc. $1,961.25 04/12/2019 Non-covered Recipient Entity
Integrated Clinical Research, LLC
M16-766 No dispute reported 06/30/2026 647589703
Principal investigator 1 LEO Pharma AS $1,976.00 04/04/2019 Non-covered Recipient Entity
INTEGRATED CLINICAL RESEARCH LLC
LONG-TERM EXTENSION TRIAL IN SUBJECTS WITH ATOPIC DERMATITIS WHO PARTICIPATED IN PREVIOUS TRALOKINUMAB TRIALS - ECZTEND No dispute reported 06/30/2026 686853847
Principal investigator 1 AbbVie, Inc. $8,208.75 04/03/2019 Non-covered Recipient Entity
Integrated Clinical Research, LLC
M16-766 No dispute reported 06/30/2026 647589705
Principal investigator 1 AbbVie, Inc. $80.00 04/02/2019 Non-covered Recipient Entity
Integrated Clinical Research, LLC
M16-045 No dispute reported 06/30/2026 647589697
Principal investigator 1 AbbVie, Inc. $1,065.00 03/29/2019 Non-covered Recipient Entity
Integrated Clinical Research, LLC
M16-045 No dispute reported 06/30/2026 647589685
Principal investigator 1 LEO Pharma AS $98.00 03/26/2019 Non-covered Recipient Entity
INTEGRATED CLINICAL RESEARCH LLC
LONG-TERM EXTENSION TRIAL IN SUBJECTS WITH ATOPIC DERMATITIS WHO PARTICIPATED IN PREVIOUS TRALOKINUMAB TRIALS - ECZTEND No dispute reported 06/30/2026 686853533
Principal investigator 1 Perrigo Company plc $1,000.00 03/20/2019 Non-covered Recipient Entity
Integrated Clinical Research, LLC
Bioequivalence study between Perrigo's product and Epiduo Forte Gel No dispute reported 06/30/2026 669929061
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $300.00 03/11/2019 Non-covered Recipient Entity
INTEGRATED CLINICAL RESEARCH LLC
A PROSPECTIVE OBSERVATIONAL STUDY OF ADULT PATIENTS RECEIVING DUPIXENT FOR ATOPIC DERMATITIS No dispute reported 06/30/2026 639735059
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $300.00 03/11/2019 Non-covered Recipient Entity
INTEGRATED CLINICAL RESEARCH LLC
A PROSPECTIVE OBSERVATIONAL STUDY OF ADULT PATIENTS RECEIVING DUPIXENT FOR ATOPIC DERMATITIS No dispute reported 06/30/2026 639735061
Recipient Bausch Health US, LLC $2,650.00 03/08/2019 Covered Recipient Physician A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, VEHICLECONTROLLED, PARALLEL-GROUP, CLINICAL STUDY COMPARING THE EFFICACY AND SAFETY OF IDP-126 GEL IN THE TREATMENT OF ACNE VULGARIS No dispute reported 06/30/2026 684337715
Recipient Bausch Health US, LLC $2,100.00 03/08/2019 Covered Recipient Physician A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, VEHICLECONTROLLED, PARALLEL-GROUP, CLINICAL STUDY COMPARING THE EFFICACY AND SAFETY OF IDP-126 GEL IN THE TREATMENT OF ACNE VULGARIS No dispute reported 06/30/2026 684337719
Principal investigator 1 AbbVie, Inc. $10,082.50 03/01/2019 Non-covered Recipient Entity
Integrated Clinical Research, LLC
M16-766 No dispute reported 06/30/2026 647589687
Principal investigator 1 AbbVie, Inc. $2,111.25 02/28/2019 Non-covered Recipient Entity
Integrated Clinical Research, LLC
M16-045 No dispute reported 06/30/2026 647589679
Principal investigator 1 LEO Pharma AS $5,405.00 02/12/2019 Non-covered Recipient Entity
INTEGRATED CLINICAL RESEARCH LLC
LONG-TERM EXTENSION TRIAL IN SUBJECTS WITH ATOPIC DERMATITIS WHO PARTICIPATED IN PREVIOUS TRALOKINUMAB TRIALS - ECZTEND No dispute reported 06/30/2026 686852037
Recipient Bausch Health US, LLC $19,000.00 02/08/2019 Covered Recipient Physician A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, VEHICLECONTROLLED, PARALLEL-GROUP, CLINICAL STUDY COMPARING THE EFFICACY AND SAFETY OF IDP-126 GEL IN THE TREATMENT OF ACNE VULGARIS No dispute reported 06/30/2026 684337701
Recipient Bausch Health US, LLC $950.00 02/08/2019 Covered Recipient Physician A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, VEHICLECONTROLLED, PARALLEL-GROUP, CLINICAL STUDY COMPARING THE EFFICACY AND SAFETY OF IDP-126 GEL IN THE TREATMENT OF ACNE VULGARIS No dispute reported 06/30/2026 684337707
Principal investigator 1 AbbVie, Inc. $9,000.00 02/06/2019 Non-covered Recipient Entity
Integrated Clinical Research, LLC
M16-046 No dispute reported 06/30/2026 647589681
Principal investigator 1 AbbVie, Inc. $9,345.00 02/04/2019 Non-covered Recipient Entity
Integrated Clinical Research, LLC
M16-766 No dispute reported 06/30/2026 647589683
Principal investigator 1 AbbVie, Inc. $5,338.75 01/29/2019 Non-covered Recipient Entity
Integrated Clinical Research, LLC
M16-045 No dispute reported 06/30/2026 647589689
Principal investigator 1 LEO Pharma AS $2,673.00 01/15/2019 Non-covered Recipient Entity
INTEGRATED CLINICAL RESEARCH LLC
TRALOKINUMAB MONOTHERAPY FOR MODERATE TO SEVERE ATOPIC DERMATITIS - ECZTRA 1 ECZEMA TRALOKINUMAB TRIAL NO. 1 ECZTRA 1 No dispute reported 06/30/2026 686851497
Principal investigator 1 AbbVie, Inc. $17,702.50 01/07/2019 Non-covered Recipient Entity
Integrated Clinical Research, LLC
M16-766 No dispute reported 06/30/2026 647589693
Principal investigator 1 Perrigo Company plc $10,425.00 01/07/2019 Non-covered Recipient Entity
Integrated Clinical Research, LLC
Bioequivalence study between Perrigo's product and Epiduo Forte Gel No dispute reported 06/30/2026 669905325
Principal investigator 1 AbbVie, Inc. $1,562.50 01/04/2019 Non-covered Recipient Entity
Integrated Clinical Research, LLC
M16-766 No dispute reported 06/30/2026 647589691